Wet Cupping Therapy in Ankylosing Spondylitis: a Multicenter Randomised Controlled Trial
Wet Cupping Therapy in Ankylosing Spondylitis: a Multicenter Randomised Controlled Trial
This study evaluates the efficacy of wet cupping therapy in patients with ankylosing spondylitis.Wet cupping therapy will be applied to half of the patients plus routine pharmaceutical treatment while the other half will receive only pharmaceutics
In addition to the medical treatment, WCT will be applied once a month, 3 times (Day 0, 30, 60) to the intervention group whereas the control group will not receive any intervention. The BASFI, BASDAI, VAS and Schober test will be applied to both groups at 0 and 3 months.
Inclusion Criteria:
Clinical diagnosis of ankylosing spondylitis 18-65 years of age Consent to participate
Exclusion Criteria:
Any ongoing medical treatment other than NSAIDs Pregnancy At least one contraindication to WCT that was detected in subject's history or in the routine blood examinations prior to enrollment (Hgb <9.5; INR> 1.2; history of hemophobia, bleeding disorder, malignant disorder).